Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06129851
Title Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Kansas Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Kansas Cancer Center Kansas City Kansas 66160 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field